Ronald Tutrone

3PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersEconomic models and forecastingPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 19, 2023
Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.

Ronald Tutrone, Ben Lowentritt, Brian Neuman

|May 16, 2023
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.

Ronald Tutrone, Ben Lowentritt, Brian Neuman

|Apr 13, 2022
A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor-targeting Agent.

Mark C Markowski, Ronald Tutrone, Christopher Pieczonka

Pageof 1